Literature DB >> 2988189

Immunohistochemical localization of HCG and its subunits in testicular germ cell tumours.

J Hustin, A M Reuter, P Franchimont.   

Abstract

Native hCG and its alpha and beta subunits have been localized by immunocytochemistry in 45 testicular germ cell tumours of the testis. Positivity was found for the three molecules in areas with trophoblastic differentiation or in syncytial-like giant cells present in some seminomas. Isolated positivity of hCG alpha was demonstrated in isolated cells usually found in areas of entodermal differentiation of immature malignant teratomas, and probably of neuro-endocrine function. This finding points to genomic derepression in tumour cells and probably also indicates a variability in subunit synthesis and a defect in subunit recombination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988189     DOI: 10.1007/bf00704302

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  11 in total

1.  Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment.

Authors:  M R Blackman; B D Weintraub; S W Rosen; I A Kourides; K Steinwascher; M H Gail
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

2.  Immunological evidence for the occurrence of luteinizing hormone-releasing factor and the alpha-subunit of glycoprotein hormones in carcinoid tumors.

Authors:  T Wahlström; M Seppälä
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

3.  hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids.

Authors:  K Oberg; L Wide
Journal:  Acta Endocrinol (Copenh)       Date:  1981-10

4.  Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Immunocytochemical analysis of tumors of 155 patients.

Authors:  P U Heitz; M Kasper; G Klöppel; J M Polak; J L Vaitukaitis
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

5.  Human chorionic gonadotrophin and alpha-fetoprotein in testicular germ cell tumours: a retrospective immunohistochemical study.

Authors:  F T Bosman; R W Giard; A C Nieuwenhuijen Kruseman; G Knijnenburg; P J Spaander
Journal:  Histopathology       Date:  1980-11       Impact factor: 5.087

6.  Serum concentration of human chorionic gonadotropin and its alpha and beta subunits. 2. Trophoblastic tumours.

Authors:  U J Gaspard; A M Reuter; J L Devìlle; Y Vrindts-Gevaert; K D Bagshawe; P Franchimont
Journal:  Clin Endocrinol (Oxf)       Date:  1980-10       Impact factor: 3.478

Review 7.  The potential value of immunohistologic techniques in the classification of ovarian and testicular tumors.

Authors:  C R Taylor; R J Kurman; N E Warner
Journal:  Hum Pathol       Date:  1978-07       Impact factor: 3.466

8.  Identification of luteinizing hormone-releasing factor and alpha subunit of glycoprotein hormones in ductal carcinoma of the mammary gland.

Authors:  M Seppälä; T Wahlström
Journal:  Int J Cancer       Date:  1980-09-15       Impact factor: 7.396

9.  Endocrine GEP-cells in primary testicular teratoma.

Authors:  O G Brodner; D Grube; V Helmstaedter; M E Kreienbrink; K Wurster; W G Forssmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

10.  Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer.

Authors:  K Mann; H J Karl
Journal:  Cancer       Date:  1983-08-15       Impact factor: 6.860

View more
  2 in total

1.  Human chorionic gonadotropin in gastric carcinoma. An immunohistochemical study suggesting independent regulation of subunits.

Authors:  M Fukayama; Y Hayashi; M Koike
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Human chorionic gonadotropin in the thymus. An immunocytochemical study on discordant expression of subunits.

Authors:  M Fukayama; Y Hayashi; Y Shiozawa; Y Maeda; M Koike
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.